Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2003-03-11
2008-12-23
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C424S001210, C424S486000
Reexamination Certificate
active
07468394
ABSTRACT:
An oil-in-water propofol emulsion that contains soybean oil and egg lecithin, which provide a source of nutrition for microorganisms. Current products include additives to act as a microbial growth retardation agent, the processes described herein detail several methods for the optimization of the innate microbial retardation capability of propofol. Using this process improves the safety of a propofol emulsion solution by controlling microbial growth without the side effects associated with growth retardation additives.
REFERENCES:
patent: 5496818 (1996-03-01), Schaupp et al.
patent: 6254853 (2001-07-01), Hendler et al.
patent: 6399087 (2002-06-01), Zhang et al.
Luo Mary Zi-ping
Zhang Jack Yongfeng
Amphastar Pharmaceuticals Inc.
Cota Albert O.
Henley, III Raymond J
LandOfFree
Sterile pharmaceutical composition and process for a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sterile pharmaceutical composition and process for a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sterile pharmaceutical composition and process for a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4025787